Background Color:
Background Pattern:
Thursday, April 25, 2019
menu click

Hepatocellular carcinoma – LUMC/Eurotransplant trial

“Overall and recurrence-free survival in patients with hepatocellular carcinoma awaiting liver transplantation after downstaging, bridging or no neoadjuvant therapy”

This portal gives access to the HCC- ET trial database.

To go to the webform logon page, click HERE.

Don't forget to sent the pathology report of the liver explant:

S.Y. Marks, Medical Staff
Eurotransplant International Foundation

P.O. Box 2304, NL
2301 CH, Leiden, The Netherlands

Or by fax:  +31 71 5790057


Marieke van den Broek, Clinical investigatorFellow Gastroenterology-Hepatology  
Susan Marks, InvestigatorInvestigator Eurotransplant  
Minneke Coenraad, InvestigatorGastroenterologist-Hepatologist  
Prof. dr. H.J. Metselaarrepresentative om behalf of the ELIAC board  
Support team Eurotransplant RegistryMarieke van Meel en Tiny Groeneveld